Protalix BioTherapeutics (PLX) P/E (2011 - 2026)
Protalix BioTherapeutics (PLX) P/E from Jun 30, 2011 to Jul 20, 2026. The TTM Protalix BioTherapeutics (PLX) P/E is 11.26. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
P/E
Annual P/E change of Protalix BioTherapeutics (PLX)
| Year | P/E | Change |
|---|---|---|
| 2026 | 11.26 | -82.10% |
| 2025 | 62.93 | -349.05% |
| 2024 | -25.27 | -292.79% |
| 2023 | 13.11 | -412.74% |
| 2022 | -4.19 | +208.22% |
| 2021 | -1.36 | -72.46% |
| 2020 | -4.94 | +87.54% |
| 2019 | -2.63 | +42.38% |
| 2018 | -1.85 | -36.92% |
| 2017 | -2.93 | +120.53% |
| 2016 | -1.33 | -84.27% |
| 2015 | -8.45 | -44.57% |
| 2014 | -15.25 | -52.70% |
| 2013 | -32.24 | +5.20% |
| 2012 | -30.64 | -0.57% |
| 2011 | -30.82 | N/A |
Comparison Protalix BioTherapeutics (PLX) P/E with competitors
Protalix BioTherapeutics (PLX) P/E is 11.26.